Runx2は頭蓋縫合の間葉系細胞においてhedgehog, Fgf, Wnt, Pthlhシグナル経路遺伝子発現を誘導し縫合閉鎖を制御する by 秦 昕
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Cleidocranial dysplasia (CCD, #119600), which is characterized by hypoplastic 
clavicles, open fontanelles, supernumerary teeth, and a short stature, is caused by 
heterozygous mutations in RUNX2. However, it currently remains unclear why suture 
closure is severely impaired in CCD patients. The closure of posterior frontal (PF) and 
sagittal (SAG) sutures was completely interrupted in Runx2+/– mice, and the 
proliferation of suture mesenchymal cells and their condensation were less than those in 
wild-type mice. To elucidate the underlying molecular mechanisms, differentially 
expressed genes between wild-type and Runx2+/– PF and SAG sutures were identified 
by microarray and real-time RT-PCR analyses. The expression of hedgehog, Fgf, Wnt, 
and Pthlh signaling pathway genes, including Gli1, Ptch1, Ihh, Fgfr2, Fgfr3, Tcf7, 
Wnt10b, and Pth1r, which were directly regulated by Runx2, was reduced in the 
sutures, but not the calvarial bone tissues of Runx2+/– mice. Bone formation and suture 
closure were enhanced in an organ culture of Runx2+/– calvariae with ligands or agonists 
of hedgehog, Fgf, Wnt, and Pthlh signaling, while they were suppressed and suture 
mesenchymal cell proliferation was decreased in an organ culture of wild-type calvariae 
with their antagonists. These results indicate that more than a half dosage of Runx2 is 
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required for the proliferation of suture mesenchymal cells, their condensation and 
commitment to osteoblast-lineage cells, and the induction of hedgehog, Fgf, Wnt, and 
Pthlh signaling pathway gene expression in sutures, but not in calvarial bone tissues, 
and also that the activation of hedgehog, Fgf, Wnt, and Pthlh signaling pathways is 
necessary for suture closure.   
 
Introduction 
     Runx2 is an essential transcription factor for osteoblast differentiation and 
chondrocyte maturation (1). Runx2-deficient (Runx2–/–) mice completely lack bone due 
to the absence of osteoblasts and the severe inhibition of chondrocyte maturation (2, 3).  
Heterozygous mutations in RUNX2 cause cleidocranial dysplasia (CCD), which is 
characterized by hypoplastic clavicles, open fontanelles, supernumerary teeth, and a 
short stature, and Runx2+/– mice also have hypoplastic clavicles and open fontanelles (2-
5). CCD patients also show a short stature, indicating that endochondral bone 
development is affected. However, bone development of the calvaria and clavicle is 
most severely affected. The calvaria is formed through intramembranous ossification, 
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while the lateral part of the clavicle is formed through intramembranous ossification and 
its medial part through endochondral ossification. In Runx2+/– mice, the formation of 
both the lateral and medial parts of the clavicle is impaired (6). A previous study 
reported that more than 70% of the Runx2 dosage was required for the normal 
development of calvaria and clavicle (7).  
     The processes underlying the closure of the posterior frontal (PF) suture are 
unique (8, 9). Mesenchymal condensation occurs at the PF suture at around P7, and 
mesenchymal cells differentiate into chondrocytes. Chondrocytes mature, cartilage is 
replaced with bone through endochondral ossification, and the suture completely closes. 
A histological analysis showed that the PF suture was the only suture that completely 
closed; therefore, the process of endochondral ossification is essential for complete 
closure. The process of endochondral ossification is not observed in other sutures, 
including the sagittal (SAG) suture.  
     The mechanisms by which Runx2 regulates calvarial development and suture 
closure remain unclear. Therefore, we initially compared the closure of the PF and SAG 
sutures between wild-type and Runx2+/– mice. Runx2+/– mice lacked cartilage formation 
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in the PF suture, and the closure of the PF and SAG sutures was completely interrupted. 
The proliferation of mesenchymal cells in sutures was severely reduced in Runx2+/– 
mice. The expression of hedgehog signaling genes, including Gli1, Ptch1, and Ihh; Fgf 
signaling genes, including Fgfr1, Fgfr2, and Fgfr3; and Wnt signaling genes, including 
Tcf7, Wnt10b, and Wnt1; and Pth1r was weaker in Runx2+/– sutures than in wild-type 
sutures. The expression of these genes was directly regulated by Runx2, and each ligand 
or agonist in these signaling pathways increased the proliferation of mesenchymal cells 
in sutures and enhanced bone formation in Runx2+/– calvariae. Furthermore, an Fgfr 
antagonist and the combination of hedgehog and Fgfr antagonists, hedgehog and Wnt 
antagonists, or hedgehog and Phtlh antagonists inhibited the proliferation of 
mesenchymal cells in sutures and bone formation. These findings indicate that Runx2 is 
required for the proliferation of mesenchymal cells in sutures, and that Runx2 regulates 
suture closure by inducing the expression of hedgehog, Fgf, Wnt, and Pthlh signaling 




The process of PF suture closure is completely interrupted in Runx2+/– mice 
     In order to elucidate the mechanisms responsible for the regulation of calvarial 
development by Runx2, we initially compared the process of PF suture closure in wild-
type and Runx2+/– mice after birth. A micro-CT analysis at P7 showed that frontal 
sutures were open in wild-type mice, while a large area of the frontal bone was not 
mineralized in Runx2+/– mice, (Fig. 1A-B’, 2M). In a histological analysis, osteogenic 
fronts, the cells of which expressed Col1a1, closely faced each other at the PF suture, 
and cells between osteogenic fronts were condensed and Col1a1 expression was 
virtually absent or extremely weak in wild-type mice (Fig. 1E, E’, M, M’), while the 
frontal bone was only observed in the lateral parts, most of the area was composed of 
mesenchymal cells that weakly expressed Col1a1, and mesenchymal condensation was 
not observed at the center of sutures in Runx2+/– mice (Fig. 1F, F’, N, N’, 2O, P). 
Neither safranin O staining nor Col2a1 expression was observed in the sutures of wild-
type and Runx2+/– mice (Fig. 1I-J’, Q-R’).   
     In a micro-CT analysis at p10, the PF suture was slightly open in wild-type mice, 
while the frontal bone area was still widely unmineralized in Runx2+/– mice (Fig. 1C-D’, 
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2M). In a histological analysis, safranin O-positive cartilaginous tissue, which contained 
Col2a1 or Col10a1-positive chondrocytes, appeared at the PF suture that was 
sandwiched by osteogenic fronts with Col1a1-positive osteoblasts in wild-type mice 
(Fig. 1G, G’, K, K’, O, O’, S, S’, U, U’), while the osteogenic fronts were still widely 
apart and the mesenchymal cells between them were not condensed and weakly 
expressed Col1a1, but not Col2a1 or Col10a1 without staining with safranin 0 in 
Runx2+/– mice (Fig. 1H, H’, L, L’, P, P’, T, T’, V, V’, 2O, P).  
     In a micro-CT analysis at P14, PF sutures were closed in wild-type mice and still 
widely open in Runx2+/– mice (Fig. 2A-B’, M). In a histological analysis, cartilaginous 
tissue was completely replaced by bone with Col1a1-positive osteoblasts and no 
staining with safranin O, Col2a1, or Col10a1 was observed in wild-type mice (Fig. 2C, 
C’, E, E’, G, G’, I, I’, K, K’), while mesenchymal cells in sutures weakly expressed 
Col1a1, but not Col2a1 or Col10a1, and neither condensation nor safranin O staining 
was observed in the sutures in Runx2+/– mice (Fig. 2D, D’, F, F’, H, H’, J, J’, L, L’, O, 
P).  
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     In a micro-CT analysis at P28, the PF suture was completely closed in wild-type 
mice, but still open in Runx2+/– mice (Supplementary Fig. 1A-D, U). In a histological 
analysis, each side of the endocranium was fused and osteoblasts that strongly 
expressed Col1a1 were observed on the surface of the endocranium, while each side of 
the exocranium was not fused, but in contact with each other at the center of sutures in 
wild-type (Supplementary Fig. 1E, F, M, N). In Runx2+/– mice, endocranial sutures were 
still open and mesenchymal cells in the sutures, which weakly expressed Col1a1, were 
not condensed. Exocranial sutures in Runx2+/– mice were also apparently opened and 
the center of exocranial sutures was rich in matrix, but contained a few cells, which 
expressed neither Col1a1 nor Col2a1, and mesenchymal cells surrounding the center of 
sutures weakly expressed Col1a1 (Supplementary Fig. 1G, H, O, P, S, T). Safranin O 
staining and Col2a1 expression were absent in PF suture of both wild-type and Runx2+/– 
mice (Supplementary Fig. 1I-L, Q-T). At 15 weeks of age, each side of the exocranium 
was in close contact with each other in wild-type mice, whereas endocranial and 
exocranial sutures were both still open and mesenchymal condensation was not 
observed in Runx2+/– mice (Supplementary Fig. 2O-V). Although the osteogenic fronts 
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closely faced each other in Runx2+/– mice at 15 weeks of age, the cell density in the PF 
sutures was less than those of wild-type and Runx2+/– mice at P5 (Supplementary Fig. 
2W). 
 
The process of SAG suture closure is completely interrupted in Runx2+/– mice 
     In micro-CT analyses at P7, P10, P14, P28, and 15 weeks of age, SAG sutures in 
wild-type mice were open apparently at P7 and slightly at P10, and closed after P14, 
while they were widely open until P28, and still overtly open at 15 weeks of age in 
Runx2+/– mice (Figs. 1 and 2, and Supplementary Figs. 1 and 2). SAG sutures were also 
examined by histological analyses at these ages and P5 (Fig. 3, Supplementary Fig. 2). 
Although cartilaginous tissue appeared under SAG sutures in the posterior part, no 
cartilaginous tissue appeared in the sutures of wild-type mice, each side of the parietal 
bone was closely facing, but not fused in wild-type mice at all ages (Fig. 3A, B, E, F, I, 
J, M, N, Supplementary Fig. 2K, L, S, T). In Runx2+/– mice, each side of the parietal 
bone was still apart, and cell density in sutures was less than that in Runx2+/+ mice at all 
ages examined (Fig. 3C, D, G, H, K, L, O, P, Q, Supplementary Fig. 2M, N, U, V, X).  
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Runx2 and Sox9 are co-expressed in mesenchymal cells in PF sutures of wild-type and 
Runx2+/– mice and osteoblast differentiation and function are not impaired in calvarial 
bone tissues of Runx2+/– mice  
     To examine whether Runx2 is expressed in mesenchymal cells in the PF suture, 
immunohistochemistry using an anti-Runx2 antibody was performed at P8 when 
osteogenic fronts closely faced each other in wild-type mice, but were widely apart in 
Runx2+/– mice (Fig. 4A-H). Runx2 was detected in mesenchymal cells in the sutures of 
both wild-type and Runx2+/– mice. The expression levels of Runx2 in calvarial bone 
tissues and sutures were also examined by real-time-RT-PCR. Runx2 expression levels 
in the posterior part of the frontal bone and in the parietal bone of Runx2+/– mice at P7 
were approximately half and less than half, respectively, compared with the respective 
bones of wild-type mice at P5 and P7 (Fig. 4M, N). The expression levels of Runx2 in 
the PF suture were approximately half of those in the posterior part of the frontal bone 
in wild-type mice at P5 and P7, while that in the PF suture in Runx2+/– mice at P7 was 
approximately half of those in the PF suture in wild-type mice at P5 and P7 (Fig. 4M). 
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The expression levels of Runx2 in SAG sutures were one third of those in the parietal 
bone in wild-type mice at P5 and P7, while that in the SAG suture in Runx2+/– mice at 
P7 was approximately half of those in the SAG suture in wild-type mice at P5 and P7 
(Fig. 4N). Since mesenchymal condensation was not observed in the PF suture of 
Runx2+/– mice, Sox9 expression was examined by immunohistochemistry at P8 (Fig. 4I-
L). In wild-type and Runx2+/– mice, Sox9 was detected in mesenchymal cells in sutures. 
Furthermore, a real-time RT-PCR analysis also showed that Sox9 was similarly 
expressed between wild-type and Runx2+/– mice in the PF and SAG sutures (Fig. 4O, P). 
Thus, mesenchymal cells in the PF and SAG sutures expressed Runx2 and Sox9 in 
wild-type and Runx2+/– mice; however, Runx2 expression levels were half of those in 
wild-type mice, while Sox9 expression levels were similar in wild-type mice and 
Runx2+/– mice.   
     Since Runx2 expression levels in Runx2+/– mice were half or less than half of 
those in wild-type mice in the posterior part of the frontal bone and in the parietal bone, 
the expression of osteoblast marker genes, including Sp7, Col1a1, Spp1, and Bglap2, 
was examined using these bone tissues (Fig. 4Q). Sp7 expression was stronger in the 
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posterior part of the frontal bone, while Col1a1 expression was stronger in the posterior 
part of the frontal bone and in the parietal bone in Runx2+/– mice than in wild-type mice, 
while Spp1 expression was weaker in the posterior part of the frontal bone in Runx2+/– 
mice. Sp7 and Spp1 expression in the parietal bone and Bglap2 expression in both bones 
were similar between wild-type and Runx2+/– mice. These results showed that osteoblast 
differentiation and function were not impaired in the bone tissues of Runx2+/– mice, 
indicating that open fontanelles and sutures are caused by the impaired commitment of 
mesenchymal cells in sutures to osteoblast lineage cells in Runx2+/– mice. 
 
The proliferation of mesenchymal cells in PF and SAG sutures is reduced in Runx2+/– 
mice 
     The proliferation of mesenchymal cells in PF and SAG sutures was examined by 
BrdU labeling (Fig. 5). As shown in Figs. 1 and 3, osteogenic fronts closely faced each 
other at the PF and SAG sutures in wild-type mice at P7, while they were largely 
separated in Runx2+/– mice. Therefore, the proliferation of mesenchymal cells in the PF 
and SAG sutures of Runx2+/– mice was examined at the center of the sutures and at both 
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sides of osteogenic fronts. BrdU-positive cell numbers were lower at the center of PF 
and SAG sutures and at the osteogenic fronts in Runx2+/– mice than in the PF and SAG 
sutures in wild-type mice, with more severe reductions being observed at the center of 
sutures than at osteogenic fronts (Fig. 5M, N). 
 
Differential expression of genes related to cell proliferation, cell adhesion, and skeletal 
development in PF sutures of wild-type and Runx2+/– mice 
     To clarify differences in gene expression in wild-type and Runx2+/– sutures, we 
extracted mRNAs from the PF sutures of wild-type mice at P5 and P7 and Runx2+/– 
mice at P7 and compared them using microarrays. In the pathway analysis, the 
pathways of focal adhesion, ECM-receptor interaction, cancer, cAMP signaling, Wnt 
signaling, and hedgehog signaling showed significant P values in comparisons between 
wild-type mice at P5 and Runx2+/– mice at P7, wild-type mice at P7 and Runx2+/– mice 
at P7, or wild-type mice at P5 and wild-type mice at P7 (Table 1). Since the 
proliferation of mesenchymal cells in sutures was reduced and mesenchymal 
condensation was absent in Runx2+/– mice at P7 (Figs. 1, 2O, and 5), we focused on 
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genes with the GO terms related to cell proliferation, cell adhesion, or skeletal 
development (Supplementary Tables 1 and 2). Based on these gene lists, we selected 
hedgehog, Fgf, Wnt, and Pthlh signaling genes, which are involved in the proliferation 
of mesenchymal cells and their differentiation into osteoblast lineage cells (10-19) 
(Table 2). We also selected the homeobox gene, Dlx5, which plays important roles in 
bone development (20), and cell adhesion-related genes, which may be involved in the 
proliferation of mesenchymal cells, their differentiation into osteoblast lineage cells, or 
their condensation (Table 2). Furthermore, the homeobox gene, Msx2, which plays an 
important role in calvarial development (21), Ncam1, which is involved in 
precartilaginous mesenchymal condensation (22), the Gli family gene, Gli3, the 
hedgehog target gene, Ptch1 (23, 24), the Fgfr family gene, Fgfr2, and the Wnt target 
gene, Dkk1 (25), were added to the list for further analyses (Table 2).  
     The expression of the selected genes was examined by real-time RT-PCR using 
RNA from wild-type PF sutures at P5 and Runx2+/– PF sutures at P7 (Fig. 6). Among 
the hedgehog signaling genes, Gli1, Ptch1, Smo, and Ihh expression was weaker and the 
expression of Gli3, the protein of which functions as a major transcriptional repressor 
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after cleavage (26), was stronger in Runx2+/– PF sutures than in wild-type PF sutures. In 
Fgf signaling genes, Fgfr1, Fgfr2, and Fgfr3 expression was reduced in Runx2+/– PF 
sutures and Fgf6 expression was unchanged. In Wnt signaling genes, Tcf7, Wnt10b, and 
Wnt1 expression was reduced, whereas Tcf7l2 expression was increased in Runx2+/– PF 
sutures, and Lrp5 expression was unchanged. The expression of Dkk1, which is a target 
gene of Wnt signaling (25), was reduced in Runx2+/– PF sutures. In Pthlh signaling 
genes, Pth1r and Pthlh expression was reduced in Runx2+/– PF sutures. In homeobox 
genes, Dlx5 was reduced, whereas Msx2 was increased in Runx2+/– PF sutures. In cell 
adhesion-related genes, Tnc, Cdh2, Itgb1, and Ncam1 expression was reduced, whereas 
Itga1 expression was increased in Runx2+/– PF sutures, and Itgb7 expression was 
unchanged. Similar changes were noted in SAG sutures, except for Smo, Fgf6, Fgfr1, 
Wnt1, and Pthlh, by the real-time RT-PCR analysis (Fig. 7).  
 
The expression of genes differentially expressed in sutures is normal in calvarial bone 
tissues in Runx2+/– mice, and Wnt signaling is down-regulated at P7 in wild-type PF 
sutures. 
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     The expression of Gli1, Ptch1, Ihh, Fgfr1, Fgfr2, Fgfr3, Tcf7, Wnt10b, Wnt1, 
Pth1r, Dlx5, Tnc, and Cdh2 was weaker, while that of Gli3 and Msx2 was stronger in 
Runx2–/– calvarial tissues, but not in Runx2+/– calvarial tissues, except for that of Dlx5 
and Cdh2, which was weaker than in wild-type calvarial tissues at E18.5 
(Supplementary Fig. 3). Furthermore, the weaker expression of Gli1, Ptch1, Ihh, Fgfr1, 
Fgfr2, Fgfr3, Tcf7, Wnt10b, and Pth1r, and stronger expression of Msx2 in the sutures 
of Runx2+/– mice than in those of wild-type mice were not observed in the neighboring 
bone tissues of Runx2+/– mice at P7 (Figs. 6, 7, 8A). These results indicated that a half 
dosage of Runx2 was sufficient for the normal expression of these genes in calvarial 
bone tissues, but not in sutures.  
     The appearance of cartilage in the PF suture, but not in the SAG suture is related 
to the activation levels of Wnt signaling, which inhibits the differentiation of 
mesenchymal cells into chondrocytes (14, 15, 27), in sutures (28). In accordance with 
this finding, the expression of the Wnt target genes, Tcf7 and Dkk1, was weaker in the 
PF suture at P7, just before the appearance of chondrocytes, than at P5, and this 
expression was also weaker than that in the SAG suture at P7 in wild-type mice, 
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indicating that Wnt signaling is activated less in the PF suture than in the SAG suture at 
P7 (Fig. 8B). Hedgehog signaling also inhibits the differentiation of mesenchymal cells 
into chondrocytes (29). Although the expression pattern of Ptch1 was similar to those of 
Tcf7 and Dkk1, Gli1 expression was detected at a similar level in the PF suture at P5 
and P7 and the SAG suture at P7. Since both are target genes of hedgehog signaling, the 
activity of hedgehog signaling was unlikely to be reduced in the PF suture at P7 (Fig. 
8B). The expression of the cell adhesion molecules, Tnc, Cdh2, Itgb1, and Ncam1, was 
weaker at P7 than at P5 in the wild-type PF suture, and was also weaker in the PF suture 
than in the SAG suture at P7, indicating that they are also not involved in mesenchymal 
condensation for cartilage formation in the PF suture (Fig. 8B).  
        
Direct regulation of the expression of Gli1, Ptch1, Ihh, Fgfr1, Fgfr2, Fgfr3, Tcf7, 
Wnt10b, Wnt1, Pth1r, Dlx5, Tnc, and Ncam1 by Runx2 
     To examine whether differentially expressed genes in Runx2+/– sutures are 
regulated by Runx2, Runx2 was overexpressed or knocked down in wild-type primary 
osteoblasts (Fig. 9). The overexpression of Runx2 induced the expression of Gli1, 
 18
Ptch1, Smo, Ihh, Fgfr1, Fgfr2, Fgfr3, Tcf7, Wnt10b, Wnt1, Pht1r, Pthlh, Dlx5, and Tnc, 
and reduced the expression of Msx2 (Fig. 9A). The knockdown of Runx2 using siRNA 
reduced the expression of Gli1, Ptch1, Ihh, Fgfr1, Fgfr2, Fgfr3, Tcf7, Wnt10b, Wnt1, 
Pht1r, Dlx5, Tnc, Cdh2, and Ncam1 (Fig. 9B). Although Gli1 and Patch1 are target 
genes of hedgehog signaling, Runx2 also induced their expression in the presence of the 
hedgehog antagonist, cyclopamine (Supplementary Fig. 4A). Furthermore, Runx2 
induced the reporter activity of the Gli1 promoter (Supplementary Fig. 4B).  
The ChIP analysis revealed the binding of endogenous Runx2 to the genome loci 
of Gli1, Gli3, Ptch1, Smo, Ihh, Fgfr1, Fgfr2, Fgfr3, Tcf7, Wnt10b, Wnt1, Pth1r, Dlx5, 
Msx2, Tnc, and Ncam1 (Fig. 10, Supplementary Fig. 4C). Therefore, these results 
indicate that Runx2 is involved in the expression of the hedgehog, Fgf, Wnt, and Pthlh 
signaling pathway genes, homeobox genes, and cell adhesion molecule genes, and also 
that Runx2 directly regulates Gli1, Ptch1, Ihh, Fgfr1, Fgfr2, Fgfr3, Tcf7, Wnt10b, Wnt1, 
Pth1r, Dlx5, and Tnc gene expression. 
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Activation of the hedgehog, Fgf, Wnt, or Pthlh signaling pathway accelerates bone 
formation and suture closure in Runx2+/– calvariae, and their antagonists inhibit suture 
closure in wild-type calvariae by reducing bone formation and the proliferation of 
mesenchymal cells in sutures. 
Since the hedgehog and Wnt signaling genes, Fgfr1-3 and Pth1r, were directly 
regulated by Runx2, we performed an organ culture of Runx2+/– calvariae in the 
presence of a hedgehog agonist (purmorphamine), Fgf2, Wnt3a, or Pth1r agonist (Pthlh 
(1-34)). All reagents increased bone formation over that with the solvent only (control) 
in the PF and SAG sutures of Runx2+/– calvariae (Fig. 11A, B, H). To investigate the 
physiological importance of these signaling pathways in suture closure, an organ culture 
of wild-type calvariae was performed in the presence of each antagonist. The toxicity of 
each antagonist and their combination was examined, and no significant increase in 
dead cell numbers was observed (Supplementary Fig. 5). Neither the hedgehog 
antagonist (cyclopamine), Fgfr antagonist (AZD4547), Wnt antagonist (Dkk1), nor 
Pth1r antagonist (Pthlh (7-34)) affected bone formation in PF or SAG sutures in wild-
type calvariae (Fig. 11C-F, I). However, the combination of hedgehog and Fgfr 
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antagonists, hedgehog and Wnt antagonists, or hedgehog and Pth1r antagonists 
significantly reduced bone formation in the PF and SAG sutures (Fig. 11G, J).  
The proliferation of mesenchymal cells in the PF suture was examined using an 
organ culture of wild-type calvariae by BrdU labeling in the presence of each 
antagonist. AZD4547, but not cyclopamine, Dkk1, or Pthlh (7-34) reduced proliferation 
(Fig. 12A, C). Furthermore, the combination of cyclopamine and AZD4547 reduced 
proliferation to a similar level as that with AZD4547 only, and the combination of 
cyclopamine and Dkk1 and that of cyclopamine and Pthlh (7-34) significantly reduced 
proliferation (Fig. 12B, D). These results indicated that the hedgehog, Fgf, Wnt, and 
Pthlh signaling pathways play important roles in suture closure by regulating bone 
formation and the proliferation of mesenchymal cells in sutures. 
  
Discussion 
     In the process of PF suture closure, chondrocytes appeared, and sutures 
completely fused through endochondral ossification in wild-type mice, whereas 
chondrocytes never appeared in the PF suture and the closure was completely 
 21
interrupted in Runx2+/– mice. SAG suture closure was also completely interrupted in 
Runx2+/– mice. Runx2 and Sox9 were co-expressed in mesenchymal cells in the sutures, 
and proliferation was reduced in Runx2+/– mice. The expression of hedgehog (Gli1, 
Ptch1, and Ihh), Fgf (Fgfr2 and Fgfr3), and Wnt (Tcf7 and Wnt10b) signaling pathway 
genes and Pth1r was reduced in the PF and SAG sutures, but not in calvarial bone 
tissues in Runx2+/– mice, although Runx2 directly regulated their expression in calvaria-
derived primary osteoblasts. Purmorphamine, FGF2, Wnt3a, and Pthlh (1-34) increased 
bone formation in the organ culture of Runx2+/– calvariae, and the combination of 
cyclopamine and AZD4547, cyclopamine and Dkk1, and cyclopamine and Pthlh (7-34) 
reduced bone formation and the proliferation of mesenchymal cells in sutures in the 
organ culture of wild-type calvariae. These results indicated that Runx2 regulates the 
proliferation of mesenchymal cells in sutures and their commitment to osteoblast-
lineage cells by inducing hedgehog, Fgf, Wnt, and Pthlh signaling pathway gene 
expression, and that the weaker induction of the expression of these signaling pathway 
genes in the sutures by a half dosage of Runx2 is likely to be a major cause of the open 
fontanelles and sutures in CCD (Fig. 12E).  
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     Ihh is essential for osteoblast differentiation in endochondral bone and is also 
involved in osteoblast differentiation in intramembranous bone (10, 30). Hedgehog 
signaling is involved in the proliferation of human mesenchymal cells in vitro (11). 
However, previous studies reported conflicting findings on the function of hedgehog 
signaling in the proliferation of osteoblast lineage cells in intramembranous bone. 
Hedgehog signaling is required for pre-osteoblast proliferation in the zebrafish opercle, 
which is a neural crest-derived dermal bone in the second pharyngeal arch (31). In 
contrast, the proliferation of osteoblast-lineage cells is not affected in the calvariae of 
Ihh–/– mice (30). FGF induces the proliferation of osteoblast lineage cells and increases 
bone formation in vivo, but inhibits osteoblast differentiation in vitro, while gain-of-
function mutations in the FGFR1, FGFR2, and FGFR3 genes cause a number of 
craniosynostosis syndromes, such as Apert, Crouzon, Pfeiffer, and Muenke syndromes 
as well as Thanatophoric dysplasia (12, 13, 32). We also recently reported that Runx2 
enhanced the proliferation of osteoblast progenitors through the direct regulation of 
Fgfr2 and Fgfr3 (33). Canonical Wnt signaling is essential for osteoblast differentiation 
in both endochondral and intramembranous bones and is required for osteoblast 
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proliferation (14-16, 27, 34). Pthlh enhances osteoblast proliferation and differentiation 
and inhibits adipocyte differentiation (17-19). Therefore, FGF signaling enhances the 
proliferation of osteoblast-lineage cells, while the hedgehog, Wnt, and Pthlh signaling 
pathways enhance their proliferation and differentiation. The reduction in these 
signaling pathway gene expression in the sutures but not in the calvarial bone tissues, 
and the normal levels of osteoblast marker gene expression in the calvarial bone tissues 
in Runx2+/– mice indicate that the proliferation of mesenchymal cells in sutures and their 
commitment to osteoblast-lineage cells require more than a half dosage of Runx2, but 
that a half dosage of Runx2 is sufficient for osteoblast differentiation and bone matrix 
production after the commitment of the mesenchymal cells to osteoblast-lineage cells. 
Impaired cell condensation at osteogenic fronts due to the reduced proliferation of 
mesenchymal cells in sutures will affect their commitment to osteoblast-lineage cells 
and also cartilage formation in PF suture.   
      Since Dlx5 enhances osteoblast differentiation and proliferation (20, 35, 36), the 
reduction of Dlx5 expression will also contribute to open fontanelles and sutures in 
Runx2+/– mice. In contrast, the up-regulation of Msx2, which regulates the proliferation 
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of osteoprogenitors at osteogenic fronts and their differentiation into osteoblasts in 
calvariae (21, 37), is unlikely to be involved in the pathogenesis of open fontanelles and 
sutures in Runx2+/– mice. Since Gli3 functions as a repressor after proteolytic processing 
(38), the up-regulation of Gli3 will contribute to reductions in hedgehog signaling in the 
sutures of Runx2+/– mice. Furthermore, reductions in the expression of cell adhesion-
related genes, including Tnc, Cdh2, Itbg1, and Ncam1, in the sutures of Runx2+/– mice 
may also contribute to the impaired condensation of mesenchymal cells and their 
commitment to osteoblast-lineage cells.    
     In conclusion, the reduced proliferation of mesenchymal cells in sutures and 
impairments in their condensation and commitment to osteoblast-lineage cells appear to 
have been caused by the insufficient induction of the hedgehog, Fgf, Wnt, and Pthlh 
signaling pathway genes due to the haplodeficiency of Runx2. Reciprocal regulation 
between Runx2 and each hedgehog, Fgf, Wnt signaling molecules will also contribute 
to the pathogenesis of open fontanelles and sutures in CCD (33, 39, 40).  
 
Materials and methods 
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Mice 
Runx2+/– mice were generated as previously described (3). Runx2+/– mice were 
backcrossed with C57BL/6 mice more than twelve times. Brother-sister mating was then 
carried out and the littermates were used for analyses. A micro-CT analysis was 
performed with µCT systems (R_mCT; Rigaku Corporation, Tokyo, Japan). Prior to the 
present study, all experimental protocols were reviewed and approved by the Animal 
Care and Use Committee of Nagasaki University Graduate School of Biomedical 
Sciences (No. 1403111129-8). 
 
Histological analyses  
Samples were fixed in 4% paraformaldehyde/0.1 M phosphate buffer, and 
embedded in paraffin. Sections (thickness of 4 or 7 μm) were stained with hematoxylin 
and eosin (H-E) and safranin O. We performed in situ hybridization using mouse Col1a1, 
Col2a1, and Col10a1 antisense probes as described previously (41), and sections were 
counterstained with methyl green. In situ hybridization using sense probes showed no 
significant signals (data not shown). Cell density and the intensity of Col1a1 expression 
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in the in situ hybridization were measured using ImageJ ver.1.43u (National Institute of 
Health, Bethesda, MD). Immunohistochemistry was performed using a mouse 
monoclonal anti-Runx2 antibody (MBL, Nagoya, Japan) and rabbit polyclonal anti-Sox9 
antibody (SIGMA). The second antibodies were Histofine Mouse Stain Kit (Nichirei, 
Tokyo Japan) in the former and Histofine Stain MAX-PO (R) (Nichirei) in the latter. 
Immunohistochemistry using a normal muse IgG2b (Dako, Glostrup, Denmark) followed 
by Histofine Mouse Stain Kit or normal rabbit IgG (Dako) followed by Histofine Stain 
MAX-PO (R) showed no significant signals (data not shown). In the analysis of BrdU 
incorporation, we subcutaneously injected mice at P7 with 100 μg BrdU/g body weight 1 
h before sacrifice. We processed embryos for a histological analysis and detected BrdU 
incorporation using a BrdU staining kit (Invitrogen). Sections were counterstained with 
hematoxylin. 
 
Gene expression microarrays and real-time reverse-transcription-polymerase chain 
reaction (RT-PCR) analyses  
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Total RNA was extracted from the sutures of four Runx2+/+ mice at P5, five 
Runx2+/+ mice at P7, and three Runx2+/- mice at P7 using ISOGEN (Wako, Osaka, 
Japan). cRNA was amplified, labeled, and hybridized to Agilent SurePrint G3 Mouse 
Gene Expression Microarray 8 × 60 K (Agilent Technologies, Santa Clara, Calif.) 
according to the manufacturer’s instructions. Hybridized microarray slides were 
scanned by means of an Agilent scanner. Relative hybridization intensities and 
background hybridization values were calculated using Agilent Feature Extraction 
Software (ver. 9.5.1.1). Real-time RT-PCR was performed using a THUNDERBIRD 
SYBR qPCR Mix (Toyobo) and Light Cycler 480 real-time PCR system (Roche 
Diagnostics). Primer sequences are shown in Supplementary Table 3. We normalized 
the values obtained to those of β-actin.  
 
Cell culture  
Primary osteoblasts were isolated from the calvariae of newborn mice by 
sequential digestion with 0.1% collagenase A and 0.2% dispase. Osteoblastic cells from 
the third to fifth fraction were pooled and used for cell culture experiments. Cells were 
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plated in 24-well plates at a density of 5×104/well in αMEM supplemented with 10% 
fetal bovine serum (FBS). At confluency, cells were infected with an adenovirus 
expressing GFP or Runx2-GFP for 2 hrs. RNA was extracted after 48 hours. A total of 
5×105 cells were subjected to electroporation with 10 pmol of siRNA for the control or 
Runx2 using the Neon Transfection System (Invitrogen). After 48 hours, medium was 
changed to osteogenic medium containing 50 μg/ml ascorbic acid and 10 mM β-
glycerophosphate. RNA was extracted after the culture for 7 days in osteogenic 
medium.  
 
Chromatin immunoprecipitation (ChIP) assay  
ChIP assays were performed using primary osteoblasts from the calvariae of 
newborn mice with a Chromatin Immunoprecipitation Assay Kit (Millipore, Billerica, 
MA). After immunoprecipitation with a rabbit monoclonal anti-Runx2 antibody (Cell 
Signaling Technology, Tokyo, Japan) or rabbit IgG (Cell Signaling Technology) and 
DNA extraction, real-time PCR was performed using the primers shown in 
Supplementary Table 3.  
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Organ culture of calvariae 
In the assessment of bone formation during a calvarial organ culture, the dorsum of 
pregnant mice was injected with calcein at E14.5 and E16.5 at a dose of 0.16 mg/10 g 
body weight. Calvariae were isolated at E17.5 and cultured on autoclaved meshes for 48 
hours in osteogenic media supplemented with 0.09 mg/mL Alizarin complex one 
(Sigma-Aldrich), with a single or combination of 5 μg/ml purmorphamine (Sigma), 100 
ng/ml FGF2 (Pepro Tech), 200 ng/ml Pthlh (1-34) (Bachem), 66.7 ng/ml Wnt3a (R&D), 
2 μg/ml cyclopamine (Selleckchem), 2 μg/ml Pthlh (7-34) (Bachem), 0.25 μg/ml 
AZD4547 (Abcam), and 100 ng/ml Dkk1 (R&D). The solvent of each reagent was 
added to the respective controls. Culture medium was changed every other day. 
Harvested explants were observed under a fluorescence microscope. Mineralized tissues 
in utero showed green fluorescence, while mineralized tissues during the organ culture 
showed red fluorescence. The area of red fluorescence were measured by ImageJ 
(National Institute of Health). In bromodeoxyuridine (BrdU) labeling of the calvarial 
organ culture, calvariae at E17.5 were cultured for 24 hours in osteogenic media 
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supplemented with 20 μM BrdU (Nacalai Tesque). BrdU incorporation was detected by 
the BrdU staining Kit (Invitrogen). 
 
Statistical analysis 
Values are shown as means ± SD. Statistical analyses of two groups were 
performed by the Student’s t-test, and those of more than three groups were performed 
by ANOVA and the Tukey-Kramer post hoc test, if not specifically stated. A p-value of 
less than 0.05 was considered to be significant. 
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Figure legends 
Fig. 1  
Micro-CT and histological analyses of the sutures in Runx2+/– mice at P7 and P10 
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The sutures of Runx2+/– (B, F, J, N, R) mice at P7 and Runx2+/– (D, H, L, P, T, V) mice 
at P10 were compared with those of Runx2+/+ (A, E, I, M, Q) mice at P7 and Runx2+/+ 
(C, G, K, O, S, U) mice at P10, respectively, by micro-CT (A-D’) and histological (E-
V’) analyses. A-D show the lateral views of heads and A’-D’ show the upper views of 
heads. The three lines in A’-D’ show the boundaries of PF and SAG sutures and 
arrowheads indicate the location of coronal sections in E-V’. (E-H’) H-E staining. (I-L’) 
Safranin O staining. (M-V’) In situ hybridization using a Col1a1 probe (M-P’), Col2a1 
probe (Q-T’), and Col10a1 probe (U-V’). The boxed regions in E-V are magnified in 
E’-V’, respectively. The red boxes in E’, F’ and H’ show the area for the measurement 
of cell density. Scale bars: 0.5 cm (A-D’) and 100 μm (E-V’). 
 
Fig. 2  
Micro-CT and histological analyses of PF sutures in Runx2+/– mice at P14 and 
quantitative analyses of the area of sutures, cell density, and Col1a1 expression 
(A-L’) The sutures of Runx2+/– (B, D, F, H, J, L) mice were compared with those of 
Runx2+/+ (A, C, E, G, I, K) mice at P14 by micro-CT (A-B’) and histological (C-L’) 
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analyses as described in Fig. 1. Scale bars: 0.5 cm (A-B’) and 100 μm (C-L’). (M and 
N) The area of PF (M) and SAG (N) sutures measured by micro-CT. The number of the 
mice analyzed; +/+: 4, +/–: 3 at P7; +/+: 6, +/–: 4 at P10; +/+: 3, +/–: 3 at P14. (O) 
Cell density of PF suture. The cell area in the red boxes in E’, F’, and H’ in Fig. 1 and 
D’ in Fig. 2 were measured, and a percentages in the total area is shown. The number of 
the mice analyzed; +/+: 3, +/–: 3 at P7; +/–: 4 at P10; +/–: 3 at P14. (P) Intensity of the 
in situ hybridization using Col1a1 probe. The gray values in the black boxes in M-P in 
Fig. 1 and G and H in Fig. 2 were measured. The gray values in Runx2+/+ mice at P7 
were set as 1, and the relative levels are shown. The number of the mice analyzed; +/+: 
3, +/–: 4 at P7; +/+: 3, +/–: 3 at P10; +/+: 4, +/–: 3 at P14.   
 
Fig. 3 
Histological analyses of the SAG suture  
(A-P) H-E staining of SAG sutures from Runx2+/+ (A, B, E, F, I, J, M, N) and Runx2+/– 
(C, D, G, H, K, L, O, P) mice at P7 (A-D), P10 (E-H), P14 (I-L), and P28 (M-P). The 
boxed region in A, C, E, G, I, K, M, and O are magnified in B, D, F, H, J, L, N, and P, 
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respectively. Scale bars: 0.1 mm. (Q) The cell density of SAG sutures. The cell area in 
the red boxes in B, D, F, H, J, L, N, and P were measured, and a percentage of the total 
area is shown. The number of the mice analyzed; +/+: 4, +/–: 3 at P7; +/+: 8, +/–: 4 at 
P10; +/+: 6, +/–: 3 at P14; +/+: 3, +/–: 4 at P28. 
 
Fig. 4  
Immunohistochemical and real-time RT-PCR analyses  
(A-D) H-E staining of coronal sections of PF sutures in Runx2+/+ (A, B) and Runx2+/– 
(C, D) mice at P8. (E-L) Immunohistochemical analysis by anti-Runx2 (E–H) and anti-
Sox9 (I–L) antibodies using serial sections of A and C. Sections were counterstained 
with methyl green. The boxed regions in A, C, E, G, I, and K are magnified in B, D, F, 
H, J, and L, respectively. Scale bars: 0.1 mm. (M-Q) Real-time RT-PCR analysis. M, 
Runx2 expression in the posterior part of the frontal bone (PFB) and PF suture in 
Runx2+/+ mice at P5 and P7 and Runx2+/– mice at P7. N, Runx2 expression in the parietal 
bone (PB) and SAG suture in Runx2+/+ mice at P5 and P7 and Runx2+/– mice at P7. O 
and P, Sox9 expression in the PF (O) and SAG (P) sutures in Runx2+/+ mice at P5 and 
 39
P7 and Runx2+/– mice at P7. Q, Sp7, Col1a1, Spp1, and Bglap2 expression in PFB and 
PB from Runx2+/+ and Runx2+/– mice at P7. The values in Runx2+/+ PFB (M) and PB (N) 
at P5, Runx2+/+ PF (O) and SAG (P) at P5, Runx2+/+ PFB (Q) were defined as 1, and 
relative levels are shown. One RNA sample for real-time RT-PCR was extracted from 
the tissues of two to five mice, and six to eight RNA samples were prepared. The 
number of the mice analyzed in M, N, and Q; P5+/+: 23, P7+/+: 22, P7+/–: 23 in PFB 
and PB; P5+/+: 18, P7+/+: 18, P7+/–: 18 in PF and SAG, and that in O and P; P5+/+: 
29, P7+/+: 22, P7+/–: 27 in PF; P5+/+: 23, P7+/+: 22, P7+/–: 23 in SAG. *, #p<0.05, 
**, ##p<0.01. In M, N, and Q, one third of the regions of PFB and PB close to the 
sutures were used for RNA preparation. 
 
Fig. 5  
BrdU labeling of PF and SAG sutures in Runx2+/+ and Runx2+/– mice at P7  
(A-L) BrdU staining in PF sutures from Runx2+/+ (A, D) and Runx2+/– (B, C, E, F) mice, 
and in SAG sutures from Runx2+/+ (G, J) and Runx2+/– (H, I, K, L) mice. Sections were 
counterstained with hematoxylin. The boxed regions in A and G are magnified in D and 
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J, respectively, and those in B and H are magnified in C, E, and F and in I, K, and L, 
respectively. Scale bars: 0.1 mm. (M, N) The number of BrdU-positive cells in the C-F 
regions of the PF suture (M) and I-L regions of the SAG suture (N) were counted and 
shown as a percentage of the number of mesenchymal cells in each region. The numbers 
on both sides of the osteogenic fronts (C and F in the PF suture and I and L in the SAG 
suture) of Runx2+/– mice were summed. The number of the mice analyzed; +/+: 8, +/–: 6 
in PF; +/+: 4, +/–: 4 in SAG. *Versus Runx2+/+ mice. *, #p<0.05, **p<0.01. 
 
Fig. 6  
Real-time RT-PCR analysis using RNA from the PF suture of Runx2+/+ mice at P5 and 
Runx2+/– mice at P7  
The values in Runx2+/+ mice at P5 were defined as 1, and relative levels are shown. One 
RNA sample for real-time RT-PCR was extracted from the tissues of three to five mice, 
and seven RNA samples were prepared. The number of the mice analyzed; +/+: 29; +/–: 
27. *Versus Runx2+/+. *p<0.05, ** p<0.01, *** p<0.001.  
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Fig. 7  
Real-time RT-PCR analysis using RNA from SAG sutures of Runx2+/+ mice at P5 and 
Runx2+/– mice at P7  
The values in Runx2+/+ mice were defined as 1, and relative levels are shown. One RNA 
sample for real-time RT-PCR was extracted from the tissues of two to three mice, and 
eight RNA samples were prepared. The number of the mice analyzed; +/+: 23, +/–: 23. 
*Versus Runx2+/+. *p<0.05, ** p<0.01, *** p<0.001.  
 
Fig. 8  
Real-time RT-PCR analysis using RNA from the posterior part of the frontal bone 
(PFB), parietal bone (PB), and PF and SAG sutures  
(A) RNA was prepared from one third of the regions of PFB and PB close to the sutures 
in Runx2+/+ and Runx2+/– mice at P7. The values in the PFB of Runx2+/+ mice were 
defined as 1, and relative levels are shown. One RNA sample for real-time RT-PCR was 
extracted from the tissues of two to four mice, and seven to eight RNA samples were 
prepared. The number of the mice analyzed; +/+: 22, +/–: 23. *Versus the PFB of 
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Runx2+/+. **p<0.01. #Versus the PB of Runx2+/+. #p<0.05, ##p<0.01. (B) RNA was 
prepared from PF suture at P5 and P7 and SAG suture at P7 in Runx2+/+ mice. The 
values in PF sutures at P5 were defined as 1, and relative levels are shown. One RNA 
sample for real-time RT-PCR was extracted from the tissues of four to five mice, and 
seven to eight RNA samples were prepared. The number of the mice analyzed; P5: 33, 
P7: 28 in PF; 28 in SAG. *Versus PF sutures at P5. *, #p<0.05, **, ## p<0.01. 
 
Fig. 9  
Real-time RT-PCR analysis of the overexpression or knockdown of Runx2 in primary 
osteoblasts  
(A) Primary osteoblasts were infected with an adenovirus expressing GFP (0.2 µl) or 
Runx2-GFP (0.5, 1, 2, and 4 µl). RNA was extracted after a culture for 48 hours. The 
values of GFP-expressing cells were defined as 1, and relative levels are shown. n=4. 
*Versus GFP. *p<0.05, ** p<0.01. (B) Primary osteoblasts were transfected with 
siRNA for control (siControl) or Runx2 (siRunx2), and RNA was extracted on day 7. 
The levels of Runx2 mRNA were examined at day 0 (48 hours after transfection), day 3, 
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and day 7. The values in siControl were defined as 1, and relative levels are shown. 
n=5. *Versus siControl. *p<0.05, ** p<0.01, *** p<0.001. 
 
Fig. 10  
ChIP assays  
DNA before immunoprecipitation (input) and after immunoprecipitation with an anti-
Runx2 or rabbit IgG was amplified by real-time PCR using primers that amplify the 
regions containing Runx2-binding motifs in the Gil1, Gil3, Ptch1, Smo, Ihh, Fgfr1, 
Fgfr2, Fgfr3, Tcf7, Wnt10b, Wnt1, Pth1r, Pthlh, Dlx5, Msx2, Tnc, Cdh2, and Ncam1 
promoters. The primers located about 100 kb downstream of the last exon of Runx2 
were used for a negative control (control). Real-time PCR was performed in duplicate. 
The value in each input was defined as 1, and relative levels are shown. Similar results 
were obtained in two to four independent experiments and representative data are 
shown. 
 
Fig. 11  
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Organ culture of calvariae with agonists or antagonists of hedgehog, Fgf, Wnt, and 
Pthlh signaling  
(A, B) Fluorescent pictures of an organ culture of Runx2+/– calvariae supplemented with 
purmorphamine, FGF2, Wnt3a, Pthlh (1-34), or solvent only (control). (C-G) 
Fluorescent pictures of an organ culture of Runx2+/+ calvariae supplemented with 
cyclopamine, AZD4547, Dkk1, Pthlh (7-34), cyclopamine and AZD4547, cyclopamine 
and Dkk1, cyclopamine and Pthlh (7-34), or solvent only (control). As described in the 
Materials and Methods, mineralized tissues in utero show green fluorescence, and 
mineralized tissues during the organ culture show red fluorescence. Scale bars: 0.5 mm. 
(H-J) The area of newly formed bones, which are lined in A-G, were measured, and the 
areas in each controls were set as 1 and relative levels are shown. The sample number: 
H, control (14) and purmorphamine (19); control (10) and FGF2 (8); control (10) and 
Wnt3a (13); control (10) and Pthlh (1-34) (17); I, control (20) and cyclopamine (16); 
control (5) and AZD4547 (5); control (8) and Dkk1 (8); control (8) and Pthlh (7-34) (8); 
J, n=8. *Versus the control. *p<0.05, **p<0.01, ***p<0.001. 
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Fig. 12  
BrdU labeling of calvariae in an organ culture  
(A) Wild-type calvariae at E17.5 were cultured for 24 hours with cyclopamine, 
AZD4547, Dkk1, or Pthlh (7-34). (B) Wild-type calvariae at E17.5 were cultured for 24 
hours with cyclopamine and AZD4547, cyclopamine and Dkk1, or cyclopamine and 
Pthlh (7-34). Sections of PF sutures were counterstained with hematoxylin. Scale bars: 
0.1 mm. (C and D) Frequencies of BrdU-positive cells in the presence of a single 
antagonist (C) and two antagonists (D). The number of BrdU-positive cells in PF 
sutures was counted and are shown as a percentage of the number of mesenchymal 
cells. n=4-7. *Versus the control, *p<0.05. The control and each antagonist (C) and the 
control and each antagonist combination (D) were compared by the Student’s t-test. (E) 
Schematic presentation of the regulation of suture closure by Runx2. Runx2 induces the 
expression of hedgehog, Fgf, Wnt, and Pthlh signaling pathway genes in suture 
mesenchymal cells, increases the proliferation and cell condensation, and promotes their 




Pathway enrichment analysis on differentially expressed genes 
Pathways with P values less than 1.0E-2 are shown. 
 
Table 2 
Summary of microarray data of selected genes  
 
Supplementary Fig. 1  
Micro-CT and histological analyses of PF sutures in Runx2+/+ and Runx2+/– mice at P28  
The PF sutures of Runx2+/– (C, D, G, H, K, L, O, P, S, T) mice were compared with 
those of Runx2+/+ (A, B, E, F, I, J, M, N, Q, R) mice at P28, by micro-CT (A-D) and 
histological (E-T) analyses as described in Fig. 1. Scale bars: 0.5 cm (A-D), 100 μm (E-
T). (U and V) The area of PF (U) and SAG (V) sutures. The number of the mice 
analyzed; +/+: 3; +/–: 4.  
 
Supplementary Fig. 2  
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Micro-CT and histological analyses of PF and SAG sutures in Runx2+/+ and Runx2+/– 
mice at P5 and 15 weeks of age  
(A-F) Analysis of PF and SAG sutures by micro-CT at 15 weeks of age. The area of PF 
(E) and SAG (F) sutures were measured. The number of the mice analyzed; +/+: 5; +/–: 
6. Scale bars: 1 cm. *Versus Runx2+/+. ***p<0.001. (G-V) H-E stained sections of PF 
(G-J) and SAG (K-N) sutures at P5 and PF (O-R) and SAG (S-V) sutures at 15 weeks 
of age in Runx2+/+ (G, H, K, L, O, P, S, T) and Runx2+/– (I, J, M, N, Q, R, U, V) mice. 
The boxed regions in G, I, K, M, O, Q, S, and U are magnified in H, J, L, N, P, R, T, 
and V, respectively. Scale bars: 0.1 mm. (W, X) The cell density of PF (W) and SAG 
(X) sutures. The cell area in the red boxes in H, J, L, N, R, T, and V were measured, and 
a percentage of the total area is shown. The number of the mice analyzed; +/+: 3, +/–: 3 
in PF and SAG at P5; +/–: 3 in PF at 15w; +/+: 6 in SAG at 15w; +/–: 9 in SAG at 15w. 
*Versus Runx2+/+ at P5. *p<0.05, **p<0.01, ## p<0.01. 
 
Supplementary Fig. 3  
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Real-time RT-PCR analysis of Runx2+/+, Runx2+/–, and Runx2–/– calvarial tissues at 
E18.5. Values in Runx2+/+ mice were defined as 1, and relative levels are shown. One 
RNA sample for real-time RT-PCR was prepared from one mouse. The number of the 
mice analyzed; +/+: 9; +/–: 5; –/–: 4. *Versus Runx2+/+. *p<0.05, ** p<0.01; #Versus 
Runx2+/–. #p<0.05, ##p<0.01. 
 
Supplementary Fig. 4  
Real-time RT-PCR analysis and reporter assay 
(A) Real-time RT-PCR analysis. Primary osteoblasts were infected with an adenovirus 
expressing GFP (0.2 µl) or Runx2-GFP (1.5 µl) without or with cyclopamine (3 and 10 
µM). Values in GFP without cyclopamine were defined as 1, and relative levels are 
shown. n=5. $p<0.05, **, ##, $$p<0.01. (B) Reporter assay of the Gil1 promoter using 
primary osteoblasts derived from wild-type newborn mice. n=4. The values in empty 
vector (pcDNA) transfection were defined as 1, and relative levels are shown. *Versus 
pcDNA. *p<0.05. (C) Validation of anti-Runx2 antibody for ChIP analysis. To validate 
the efficiency of the anti-Runx2 antibody for immunoprecipitation, 
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immunoprecipitation reactions using the cell lysates from primary osteoblasts were 
performed with the anti-Runx2 antibody (Cell Signaling) or normal rabbit IgG (Cell 
Signaling). Runx2 in the immunoprecipitates or cell lysates before 
immunoprecipitation (Input) was detected by Western blot using the anti-Runx2 
antibody (Cell Signaling). 
 
Supplementary Fig. 5  
Trypan blue assessment of cell viability  
(A) The toxicity of cyclopamine, AZD4547, Dkk1, Pthlh (7-34), cyclopamine and 
AZD4547, cyclopamine and Dkk1, or cyclopamine and Pthlh (7-34) at the same 
concentration with an organ culture (Figs. 11 and 12) was examined by trypan blue 
staining using MC3T3-E1 cells. A total of 3 × 104 cells/well in 24-well plates were 
cultured for 24 hrs with the antagonists, and then stained with trypan blue. (B) 
Frequencies of trypan blue-positive cells. n=4. 
 
Supplementary Table 1-(1) 
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Microarray data of up- and down-regulated genes related to cell proliferation in 
comparisons between Runx2+/+ PF sutures at P5 and Runx2+/– PF sutures at P7 
The up-regulated genes (Z score ≥ 2.0 and ratio ≥ 1.5) and down-regulated genes (Z 
score ≤ –2.0 and ratio ≤ 0.66) in the comparison between Runx2+/+ PF sutures at P5 and 
Runx2+/– PF sutures at P7 are shown in Supplementary Table 1-(1-3). The genes 
selected in Table 2 are shown in red in Supplementary Tables 1 and 2. 
 
Supplementary Table 1-(2) 
Microarray data of up- and down-regulated genes related to cell adhesion in 
comparisons between Runx2+/+ PF sutures at P5 and Runx2+/– PF sutures at P7 
 
Supplementary Table 1-(3)  
Microarray data of up- and down-regulated genes related to skeletal development in 
comparisons between Runx2+/+ PF sutures at P5 and Runx2+/– PF sutures at P7 
 
Supplementary Table 2-(1)  
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Microarray data of up- and down-regulated genes related to cell proliferation in 
comparisons between Runx2+/+ and Runx2+/– PF sutures at P7 
The up-regulated genes (Z score ≥ 2.0 and ratio ≥ 1.5) and down-regulated genes (Z 
score ≤ –2.0 and ratio ≤ 0.66) in the comparison between Runx2+/– and Runx2+/+ PF 
sutures at P7 are shown in Table 2-(1-3).  
 
Supplementary Table 2-(2) 
Microarray data of up- and down-regulated genes related to cell adhesion in 
comparisons between Runx2+/+ and Runx2+/– PF sutures at P7 
 
Supplementary Table 2-(3) 
Microarray data of up- and down-regulated genes related to skeletal development in 
comparisons between Runx2+/+ and Runx2+/– PF sutures at P7 
 
Supplementary Table 3 




Reporter assay  
Primary osteoblasts were transfected with a 3.5-kb Gli1 promoter construct *1 (kindly 
provided by Dr. S. Ishii) and pRL-TK (Promega) with a Runx2-expressing vector 
(pcDNA-Runx2) or empty vector (pcDNA) using X-tremeGENE9 (Roche Diagnostics). 
 
Immunoprecipitation (IP) and Western blot analysis 
A total of 5 × 106 primary osteoblasts were treated with IP lysis buffer, according to 
the manuals of Pierce™ ClassicCo-Immunoprecipitation Kit (Thermo Fisher 
Scientific, Rockford, IL). The cell lysates were incubated with anti-Runx2 (Cell 
Signaling, Danvers, MA, USA) overnight at 4 °C, and then incubated with protein 
A/G magnetic beads for 2 hours. Western blot analysis was performed using anti-
Runx2 antibody (Cell Signaling) and HRP-conjugated secondary anti-Rabbit antibody 
(Cell Signaling). The bands were detected using Pierce Western Blotting Substrate 
Plus Kit (Thermo Fisher Scientific). 
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*1. Dai P, Akimaru H, Tanaka Y, Maekawa T, Nakafuku M, Ishii S. (1999) 
Sonic Hedgehog-induced activation of the Gli1 promoter is mediated by 
GLI3. J. Biol. Chem., 274, 8143-8152. 
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